Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 crore
Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company’s second quarter performance was subdued, mainly due to macro-environment factors and higher competitive intensity for some products in the US.
